{
    "root": "5995f9f1-37ee-426b-adda-04d400fec512",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amlodipine Besylate",
    "value": "20250305",
    "ingredients": [
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "indications": "Amlodipine besylate tablets is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension (1.1) Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Coronary Artery Disease (1.2) Chronic Stable Angina Vasospastic Angina (Prinzmetal’s or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%",
    "contraindications": "Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg once daily. (2.2) Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. (2.2)",
    "warningsAndPrecautions": "5 mg Tablets\n                  \n                  Amlodipine besylate tablets, USP 5 mg (amlodipine besylate equivalent to 5 mg of amlodipine per tablet) are available for oral administration as white to off-white, round unscored tablets, debossed with “C46” on one side and plain on other side. They are supplied as follows:\n                  Bottles of 90 (NDC 51407-950-90)\n                  Bottles of 1,000 (NDC 51407-950-10)\n                  \n                     10 mg Tablets\n                  \n                  Amlodipine besylate tablets, USP 10 mg (amlodipine besylate equivalent to 10 mg of amlodipine per tablet) are available for oral administration as white to off-white, round unscored tablets, debossed with “C47” on one side and plain on other side. They are supplied as follows:\n                  Bottles of 90 (NDC 51407-951-90)\n                  Bottles of 1,000 (NDC 51407-951-10)\n                  \n                     Storage\n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].\n                  PROTECT FROM LIGHT.\n                  Dispense in tight, light-resistant, child resistant containers (USP).\n                  \n                     Marketed by: GSMS, Incorporated Camarillo, CA 93012 USA\n                  \n                     Manufactured by: CorePharma, LLC. 215 Wood Ave, Middlesex, NJ 08846\n                  Revised: 02/2025\n                  40356",
    "adverseReactions": "Amlodipine besylate tablets are contraindicated in patients with known sensitivity to amlodipine besylate."
}